Par avoids pay-for-delay suit after court accepts payment was ‘fair’

10-03-2020

Sarah Morgan

Par avoids pay-for-delay suit after court accepts payment was ‘fair’

Panchenko Vladimir / Shutterstock.com

A Virginia judge has approved Par Pharmaceutical’s settlement with a group of direct purchasers, allowing the pharmaceutical company to escape a pay-for-delay lawsuit.


Par Pharmaceutical, Merck, Glenmark, generics, antitrust, pay-for-delay, competition, settlement, Zetia

LSIPR